UCB Can't Halt Drug Ingredient Import In Vimpat IP Case
A Kentucky federal judge refused to block Catalent Pharma Solutions Inc. from importing a key ingredient of the anti-epileptic drug Vimpat, saying the company is protected by a safe harbor provision...To view the full article, register now.
Already a subscriber? Click here to view full article